Two simple, economical, rapid, precise, and accurate methods for simultaneous determination of olmesartan medoxomil and hydrochlorothiazide in combined tablet dosage form have been developed. The first method is based on ratio spectra derivative spectrophotometry, and the second method is zero-crossing difference spectrophotometry. The amplitudes in the first derivative of the corresponding ratio spectra at 231.0 and 271.0 nm were selected to determine olmesartan medoxomil and hydrochlorothiazide, respectively. Measurements of absorbance were carried out at zero-crossing wavelengths 257.8 and 240.2 nm for olmesartan medoxomil and hydrochlorothiazide by zero-crossing difference spectrophotometric method. Beer’s law is obeyed in the concentration range of 08–24 µg/mL for olmesartan medoxomil (OLM) and 05–15 µg/mL for hydrochlorothiazide (HCT) by ratio spectra derivative and 05–30 µg/mL for OLM and HCT by zero-crossing difference spectrophotometric method. The results of the assay were found to be 100.46 ± 0.95 for OLM and 100.4 ± 0.27 for HCT by ratio spectra derivative and 99.06 ± 1.14 for OLM and 100.05 ± 0.90 for HCT by zero-crossing difference spectrophotometric method. These methods passes F test and t test. Both methods were validated statistically and by performing recovery study.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Sellin L, Stegbauer J, Laeis P, Rump LC. Adding hydrochlorothiazide to olmesartan dose dependently improves 24-h blood pressure and response rates in mild-to-moderate hypertension. J Hypertens. 2005;23:2083–92.
Klaus OS. Olmesartan compared with other angiotensin II receptor antagonists: head-to-head trials. Clin Ther. 2004;26:A33–7.
Gonzalez L, Lopez JA, Alonso RM, Jimenez RM. A fast screening method for the determination of angiotensin II receptor antagonists in human plasma by high-performance liquid chromatography with fluorimetric detection. J Chromatogr. 2002;949:49–60.
Shah NJ, Suhagia BN, Shah RR, Patel NM. Development and validation of a simultaneous HPTLC method for the estimation of olmesartan medoxomil and hydrochlorothiazide in tablet dosage form. Indian J Pharma Sci. 2007;69(6):834–6.
Dongyang L, Pei H, Nobuko M, Xiaoming L, Li L, Ji J. Quantitative determination of olmesartan in human plasma and urine by liquid chromatography coupled to tandem mass spectrometry. J Chromatogr B. 2007;856:190–7.
Vaidya VV, Roy MN, Yetal SM, Joshi SS, Parekh SA. LC-MS-MS determination of olmesartan in human plasma. Chromatographia. 2008;67:147–50.
The Merck index, 13th edition, vol. 4802, p. 6909. White House Station, NJ: Merck Research Laboratories, Division of Merck and Co. Inc.; 1997.
Gandhimathi M, Vikram K, Baskaran A, Ravi TK. Simultaneous estimation of losartan potassium and hydrochlorthiazide in combination. Indian J Pharm Sci. 2001;63(2):165–6.
Lande NR, Shetkar BM, Kadam SS, Dhaneswar SR. Simultaneous spectrometric estimation of losartan potassium and hydrochlorothiazide from combined dosage form. Indian J Pharm Sci. 1994;56(1):66–9.
Farthing D, Fakhry I, Ripley E, Sica D. Simple method for determination of hydrochlorothiazide in human urine by high performance liquid chromatography utilizing narrow-bore chromatography. J Pharm Biomed Anal. 1998;17:1455–9.
Papadoyannins IN, Samanidou VF, Georga KA, Georgarakis E. High-pressure liquid-chromatography determination of hydrochlorothiazide in pharmaceutical preparations and human serum after solid-phase extraction. J Liq Chromatogr Relat Technol. 1998;21:1671–83.
Fei L, Yu X, Shu G, Jundong Z, Qingxiang G. Determination of hydrochlorothiazide in human plasma by liquid chromatography/tandem mass spectrometry. J Pharm Biomed Anal. 2007;44:1187–91.
Shetkar PB, Shinde VM. Simultaneous determination of enalapril maleate and hydrochlorothiazide in tablets by reversed phase high performance liquid chromatography. Anal Lett. 1997;30:1143–52.
Belal F, Al-Zaagi IA, Gadkariem EA, Abounassif MA. A stability-indicating LC method for the simultaneous determination of ramipril and hydrochlorothiazide in dosage forms. J Pharm Biomed Anal. 2001;24:335–42.
Erk N. Analysis of binary mixtures of losartan potassium and hydrochlorothiazide by using HPLC, ratio derivative spectrophotometric and compensation technique. J Pharm Biomed Anal. 2001;24:603–11.
Shah NJ, Suhagia BN, Shah RR, Shah PB. Development and validation of HPTLC method for simultaneous estimation of telmesartan and hydrochlorothiazide. Indian J Pham Sci. 2007;69(2):202–5.
Maheswari R, Mayeswari SD, Surendra K, Gunasekaran GV, Shanmugasurendaram P. Simultaneous estimation of telmisartan and hydrochlorothiazide in tablet dosage form by HPTLC. Asian J Chem. 2007;19:5582.
Sayed AY, Salem NA. Recent development of derivative spectrophotometry and their analytical applications. Analytical Sci. 2005;21:595.
Basilio M. Determination of Anafranil in pharmaceuticals by difference and difference-derivative spectrophotometric method. Analytical Letters. 1996;29(9):1551–62.
Beckett SJB. Practical pharmaceutical chemistry, 4th edition, part 2. Delhi: CBS Publishers & Distributors; 2004. p. 293–96.
ICH guideline validation of analytical procedures: text and methodology; 2005;Q2 (R1)
The authors express their gratitude to Ajanta Pharmaceutical Pvt. Ltd. (Paithan) and Glen mark Pharma. Ltd (Nashik) for providing gift samples of pure olmesartan medoxomil for hydrochlorothiazide, respectively. Thanks are also extended to Management and Principal, MGV’s Pharmacy College for providing necessary facilities.
About this article
Cite this article
Rote, A.R., Bari, P.D. Ratio Spectra Derivative and Zero-Crossing Difference Spectrophotometric Determination of Olmesartan Medoxomil and Hydrochlorothiazide in Combined Pharmaceutical Dosage Form. AAPS PharmSciTech 10, 1200–1205 (2009). https://doi.org/10.1208/s12249-009-9318-y